Table 3

 Mean improvement from baseline to week 14 in SF-36 scores by categories of ACR20 and PASI75 response or non-response

ACR20 non-respondersACR20 responders
PASI75 non-respondersPASI75 respondersPASI75 non-respondersPASI75 responders
ACR, American College of Rheumatology; PASI, Psoriasis Area and Severity Index; PCS, physical component summary; MCS, mental component summary; PF, physical functioning; RP, role-physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role-emotional; MH, mental health; SF-36, Short Form-36.
PCS 0.65.79.313.0
MCS −1.03.51.95.4
PF−1.69.618.227.6
RP3.628.330.038.6
BP3.112.022.332.5
GH−2.57.87.818.4
VT0.69.613.818.3
SF−1.09.211.519.9
RE−3.617.46.722.7
MH−1.76.37.513.3